Yale Innovation Summit, May 29-30, New Haven, CT. WESTPORT, CT / ACCESSWIRE / May 16, 2024 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct", "CYductDX", or the "Company"), an innovator in precision breast health enabled by non-invasive intraductal platforms, today announced it is pleased to present at the 2024 Yale Innovation Summit, being held from May 29-30 in New Haven, CT.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Dom L. Gatto CEO | OTC PINK Exchange | 23256Q105 CUSIP |
| US Country | 3 Employees | - Last Dividend | 24 Sep 2015 Last Split | - IPO Date |
CYduct Diagnostics, Inc. is a healthcare instrument company that is on the forefront of developing and marketing advanced technology, applications, medical devices, and procedural techniques aimed at improving the screening, diagnosis, treatment, and management of various diseases and medical conditions. Originally known as Solos Endoscopy, Inc., the company underwent a name change to CYduct Diagnostics, Inc. in December 2020. With its foundation dating back to 1986, CYduct Diagnostics has established itself as a significant player in the medical technology field, operating out of its headquarters in Westport, Connecticut.
The company offers a wide range of products and services, detailed as follows: